| Patent | Date |
|---|
Pharmaceutical Preparation For Use In Treating Epstein- Barr Virus Positive Patients With Reactivation Phenomenon- Associated Diseases
App 20210206853 - Lindhofer; Horst ; et al. | 2021-07-08 |
Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
App 20210015917 - HEISS; Markus M. ; et al. | 2021-01-21 |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
Grant 10,576,149 - Heiss , et al. | 2020-03-03 |
Combination Of T-Cell Redirecting Multifunctional Antibodies With Immune Checkpoint Modulators And Uses Thereof
App 20190375852 - LINDHOFER; Horst ; et al. | 2019-12-12 |
Multispecific Antibodies For Use In The Treatment Of A Neoplasm Of The Urinary Tract
App 20190054170 - Lindhofer; Horst ; et al. | 2019-02-21 |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
Grant 10,071,158 - Heiss , et al. September 11, 2 | 2018-09-11 |
Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
App 20180236067 - Heiss; Markus M. ; et al. | 2018-08-23 |
Initial relative lymphocyte count as predictive biomarker
Grant 9,772,327 - Lindhofer , et al. September 26, 2 | 2017-09-26 |
Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
Grant 9,750,806 - Lindhofer September 5, 2 | 2017-09-05 |
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
App 20170224818 - LINDHOFER; Horst ; et al. | 2017-08-10 |
Removal of tumor cells from intraoperative autologous blood salvage
Grant 9,605,242 - Lindhofer , et al. March 28, 2 | 2017-03-28 |
Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens
Grant 9,017,676 - Lindhofer April 28, 2 | 2015-04-28 |
Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
App 20150086550 - Heiss; Markus M. ; et al. | 2015-03-26 |
Initial Relative Lymphocyte Count As Predictive Biomarker
App 20150037278 - Lindhofer; Horst ; et al. | 2015-02-05 |
Removal Of Tumor Cells From Intraoperative Autologous Blood Salvage
App 20140369985 - Lindhofer; Horst ; et al. | 2014-12-18 |
Vaccine Preparation Containing Trifunctional Antibodies With Antigen Immunogenicity Enhancer Properties
App 20140286999 - Lindhofer; Horst | 2014-09-25 |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
Grant 8,709,421 - Heiss , et al. April 29, 2 | 2014-04-29 |
Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell dissemination
Grant 8,663,638 - Lindhofer , et al. March 4, 2 | 2014-03-04 |
Correlation Of De Novo-induced Tumor-associated Humoral Immune Responses With Improved Clinical Outcome
App 20130309234 - Lindhofer; Horst | 2013-11-21 |
Use Of Trifunctional Bispecific And Trispecific Antibodies For The Treatment Of Malignant Ascites
App 20130095106 - Lindhofer; Horst | 2013-04-18 |
Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
Grant 8,277,806 - Lindhofer October 2, 2 | 2012-10-02 |
Use Of Trifunctional Bispecific Antibodies For The Treatment Of Tumors Associated With The Cd133+/epcam+ Cancer Stem Cells
App 20120095192 - Lindhofer; Horst | 2012-04-19 |
Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
Grant 8,066,989 - Lindhofer , et al. November 29, 2 | 2011-11-29 |
Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
Grant 8,012,470 - Lindhofer , et al. September 6, 2 | 2011-09-06 |
Intraoperative Trifunctional Antibody Application For Prophylaxis Of Intraperitoneal Tumor Cell Dissemination
App 20100322933 - Lindhofer; Horst ; et al. | 2010-12-23 |
Destruction of Tumor Cells by Trifunctional Bispecific Antibodies With Low to Medium Expression Levels of Tumor-Associated Target Antigens
App 20100178298 - Lindhofer; Horst | 2010-07-15 |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
App 20090191201 - Heiss; Markus M. ; et al. | 2009-07-30 |
Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
App 20060115481 - Lindhofer; Horst ; et al. | 2006-06-01 |
Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
Grant 7,018,632 - Lindhofer , et al. March 28, 2 | 2006-03-28 |
Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
Grant 6,994,853 - Lindhofer , et al. February 7, 2 | 2006-02-07 |
Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
App 20050255110 - Lindhofer, Horst ; et al. | 2005-11-17 |
Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
App 20030223999 - Lindhofer, Horst | 2003-12-04 |
Bi-and trispecific antibodies for the induction of anti-tumor immunity
Grant 6,551,592 - Lindhofer , et al. April 22, 2 | 2003-04-22 |
Bi-and Trispecific Antibodies For The Induction Of Anti-tumor Immunity
App 20020051780 - LINDHOFER, HORST ; et al. | 2002-05-02 |
Method For Ex Vivo Immunization Using Heterologous Intact Bispecific And/or Trispecific Antibodies
App 20020009430 - LINDHOFER, HORST ; et al. | 2002-01-24 |
Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
Grant 6,322,787 - Mocikat , et al. November 27, 2 | 2001-11-27 |
Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
Grant 6,210,668 - Lindhofer , et al. April 3, 2 | 2001-04-03 |
Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
Grant 5,985,276 - Lindhofer , et al. November 16, 1 | 1999-11-16 |
Method for producing heterologous bi-specific antibodies
Grant 5,945,311 - Lindhofer , et al. August 31, 1 | 1999-08-31 |
| 